CIK 0000849146 · Accelerated filer<br>Smaller reporting company
Lifevantage Corp
Sign in to watch- Ticker
- LFVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 900224471
- Phone
- 801-432-9000
- Business address
- 3300 TRIUMPH BLVD, SUITE 700, LEHI, UT, 84043
- Former names
- LIFELINE THERAPEUTICS, INC., YAAK RIVER RESOURCES INC
- Open-market buys, last 90 days
- $6,071
- in 1 filing
- Open-market sales, last 90 days
- $55,649
- in 1 filing
Net −$49,578. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-07 | Cunningham Kristen Chief Sales Officer | Grant or award | +32,850 | 152,375 | ||
| 2026-10-07 | Cunningham Kristen Chief Sales Officer | Grant or award · Performance Restricted Stock Units | +49,275 | 49,275 | ||
| 2026-10-01 | Cunningham Kristen Chief Sales Officer | Shares withheld for taxes | −637 | $6.24 | $4K | 119,525 |
| 2026-09-14 | Cunningham Kristen Chief Sales Officer | Sale | −8,901 | $6.18 | $55K | 120,162 |
| 2026-09-11 | Cunningham Kristen Chief Sales Officer | Sale | −100 | $6.41 | $641 | 129,063 |
| 2026-09-10 | Cunningham Kristen Chief Sales Officer | Shares withheld for taxes | −2,254 | $6.37 | $14K | 129,163 |
| 2026-07-01 | Cunningham Kristen Chief Sales Officer | Shares withheld for taxes | −1,717 | $6.25 | $11K | 131,417 |
| 2026-04-01 | Cunningham Kristen Chief Sales Officer | Shares withheld for taxes | −1,928 | $4.20 | $8K | 133,134 |
| 2026-01-01 | Cunningham Kristen Chief Sales Officer | Shares withheld for taxes | −1,926 | $6.16 | $12K | 135,060 |
| 2025-10-01 | Cunningham Kristen Chief Sales Officer | Shares withheld for taxes | −1,720 | $9.56 | $16K | 136,986 |
| 2025-08-31 | Cunningham Kristen Chief Sales Officer | Option exercise | +17,752 | 134,357 | ||
| 2025-08-31 | Cunningham Kristen Chief Sales Officer | Option exercise | +26,150 | 160,507 | ||
| 2025-08-31 | Cunningham Kristen Chief Sales Officer | Shares withheld for taxes | −21,801 | $13.10 | $286K | 138,706 |
| 2025-08-31 | Cunningham Kristen Chief Sales Officer | Option exercise · Performance Restricted Stock Units | −17,752 | 5,917 | ||
| 2025-08-31 | Cunningham Kristen Chief Sales Officer | Option exercise · Performance Restricted Stock Units | −26,150 | 13,075 | ||
| 2025-08-26 | Cunningham Kristen Chief Sales Officer | Grant or award | +12,349 | 116,351 | ||
| 2025-08-26 | Cunningham Kristen Chief Sales Officer | Grant or award · Performance Restricted Stock Units | +18,524 | 18,524 | ||
| 2025-07-01 | Cunningham Kristen Chief Sales Officer | Option exercise | +3,001 | 107,389 | ||
| 2025-07-01 | Cunningham Kristen Chief Sales Officer | Shares withheld for taxes | −3,387 | $13.39 | $45K | 104,002 |
| 2025-07-01 | Cunningham Kristen Chief Sales Officer | Option exercise · Performance Restricted Stock Units | −3,001 | 0 |
Page 1 of 2 · 33 trades